Chemotherapy-induced Thrombocytopenia clinical trials at University of California Health

1 in progress, 0 open to eligible people

Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Sorry, in progress, not accepting new patients
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy
at UC Irvine

Last updated: January 23, 2026